119 related articles for article (PubMed ID: 36702387)
1. Injectable rhein-assisted crosslinked hydrogel for efficient local osteosarcoma chemotherapy.
Zhang L; Liu YX; Yao YT; Zhou TJ; Jiang HL; Li CJ
Int J Pharm; 2023 Mar; 634():122637. PubMed ID: 36702387
[TBL] [Abstract][Full Text] [Related]
2. In situ Co-Delivery of Doxorubicin and Cisplatin by Injectable Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment.
Si M; Xia Y; Cong M; Wang D; Hou Y; Ma H
Int J Nanomedicine; 2022; 17():1309-1322. PubMed ID: 35345787
[TBL] [Abstract][Full Text] [Related]
3. Injectable thermosensitive black phosphorus nanosheet- and doxorubicin-loaded hydrogel for synergistic bone tumor photothermal-chemotherapy and osteogenesis enhancement.
Li S; Qing Y; Lou Y; Li R; Wang H; Wang X; Ying B; Tang X; Qin Y
Int J Biol Macromol; 2023 Jun; 239():124209. PubMed ID: 36972826
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin and CD‑CUR inclusion complex co‑loaded in thermosensitive hydrogel PLGA‑PEG‑PLGA localized administration for osteosarcoma.
Yang Z; Liu J; Lu Y
Int J Oncol; 2020 Aug; 57(2):433-444. PubMed ID: 32468050
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression.
Sugiu K; Tazawa H; Hasei J; Yamakawa Y; Omori T; Komatsubara T; Mochizuki Y; Kondo H; Osaki S; Fujiwara T; Yoshida A; Kunisada T; Ueda K; Urata Y; Kagawa S; Ozaki T; Fujiwara T
Cancer Chemother Pharmacol; 2021 Sep; 88(3):513-524. PubMed ID: 34114067
[TBL] [Abstract][Full Text] [Related]
6. CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma.
Cao J; Zhu C; Cao Z; Ke X
Int J Biol Macromol; 2024 May; 267(Pt 2):130915. PubMed ID: 38561118
[TBL] [Abstract][Full Text] [Related]
7. PLK1shRNA and doxorubicin co-loaded thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma treatment.
Ma H; He C; Cheng Y; Li D; Gong Y; Liu J; Tian H; Chen X
Biomaterials; 2014 Oct; 35(30):8723-34. PubMed ID: 25017095
[TBL] [Abstract][Full Text] [Related]
8. Injectable Magnetic Hydrogel Filler for Synergistic Bone Tumor Hyperthermia Chemotherapy.
Hu P; Lu J; Li C; He Z; Wang X; Pan Y; Zhao L
ACS Appl Bio Mater; 2024 Mar; 7(3):1569-1578. PubMed ID: 38349029
[TBL] [Abstract][Full Text] [Related]
9. The effect of PLGA-based hydrogel scaffold for improving the drug maximum-tolerated dose for in situ osteosarcoma treatment.
Yang Z; Yu S; Li D; Gong Y; Zang J; Liu J; Chen X
Colloids Surf B Biointerfaces; 2018 Dec; 172():387-394. PubMed ID: 30193198
[TBL] [Abstract][Full Text] [Related]
10. IL-11Rα-targeted nanostrategy empowers chemotherapy of relapsed and patient-derived osteosarcoma.
Jiang J; Wang R; Yang L; Sha Y; Zhao S; Guo J; Chen D; Zhong Z; Meng F
J Control Release; 2022 Oct; 350():460-470. PubMed ID: 36041590
[TBL] [Abstract][Full Text] [Related]
11. Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human osteosarcoma.
Liu Y; Raina DB; Sebastian S; Nagesh H; Isaksson H; Engellau J; Lidgren L; Tägil M
Acta Biomater; 2021 Sep; 131():555-571. PubMed ID: 34271171
[TBL] [Abstract][Full Text] [Related]
12. Sequentially degradable hydrogel-microsphere loaded with doxorubicin and pioglitazone synergistically inhibits cancer stemness of osteosarcoma.
Cao J; Du X; Zhao H; Zhu C; Li C; Zhang X; Wei L; Ke X
Biomed Pharmacother; 2023 Sep; 165():115096. PubMed ID: 37421781
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-Loaded Microalgal Delivery System for Combined Chemotherapy and Enhanced Photodynamic Therapy of Osteosarcoma.
An X; Zhong D; Wu W; Wang R; Yang L; Jiang Q; Zhou M; Xu X
ACS Appl Mater Interfaces; 2024 Feb; 16(6):6868-6878. PubMed ID: 38294964
[TBL] [Abstract][Full Text] [Related]
14. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
[TBL] [Abstract][Full Text] [Related]
15. A conductive gelatin methacrylamide hydrogel for synergistic therapy of osteosarcoma and potential bone regeneration.
Liu X; Zhang Y; Wu H; Tang J; Zhou J; Zhao J; Wang S
Int J Biol Macromol; 2023 Feb; 228():111-122. PubMed ID: 36563819
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis.
Wei H; Chen F; Chen J; Lin H; Wang S; Wang Y; Wu C; Lin J; Zhong G
Int J Nanomedicine; 2022; 17():3483-3495. PubMed ID: 35959282
[TBL] [Abstract][Full Text] [Related]
18. Has_circ_0010220 regulates the miR-574-3p/IL-6 axis to increase doxorubicin resistance in osteosarcoma.
Gu Y; Wang G; Ran B
Hum Exp Toxicol; 2022; 41():9603271221131307. PubMed ID: 36250452
[TBL] [Abstract][Full Text] [Related]
19. Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma.
Wu W; Dai Y; Liu H; Cheng R; Ni Q; Ye T; Cui W
Drug Deliv; 2018 Nov; 25(1):1642-1651. PubMed ID: 30799654
[TBL] [Abstract][Full Text] [Related]
20. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma.
Qiu R; Sun D; Bai Y; Li J; Wang L
Drug Deliv; 2020 Nov; 27(1):1704-1717. PubMed ID: 33305647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
